Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

281 trials

NCT07089121
Recruiting
Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Phase 1/2 · United States · 3 sites
Registry update: 27 Jul 2026
NCT07315087
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 20 Jan 2026
NCT07331467
Recruiting
Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE
Phase 1 · China · 1 site
Registry update: 12 Jan 2026
NCT07330245
Recruiting
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
Not applicable · Italy · 22 sites
Registry update: 21 Sept 2026
NCT06975787
Recruiting
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Phase 1 · Germany, Spain, France, South Korea, Taiwan, United States · 20 sites
Registry update: 27 Oct 2026
NCT07323173
Recruiting
A Study to Assess the Safety and PK/PD of LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus
Phase 1 · China · 12 sites
Registry update: 21 Oct 2026
NCT07444307
Recruiting
A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus
Phase 1 · China · 3 sites
Registry update: 2 Mar 2026
NCT07138898
Recruiting
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Phase 2 · United States · 1 site
Registry update: 9 Jul 2026
NCT07340463
Recruiting
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Phase 2 · China · 1 site
Registry update: 12 Mar 2026
2024-518528-54-00
Recruiting
A Phase 1 Study of the Safety and Preliminary Efficacy of CTX112 in Adult Subjects With Refractory Autoimmune Disease.
Phase 1 · Germany, Spain, France · 13 sites
Registry update: 17 Aug 2026
NCT07201558
Recruiting
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Phase 1 · Australia, Belgium, Brazil, China, Germany, Spain, United Kingdom, Taiwan, Ukraine, United States · 34 sites
Registry update: 28 Oct 2026
NCT07180537
Recruiting
Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Not applicable · United States · 1 site
Registry update: 10 Aug 2026
NCT07282392
Recruiting
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)
Not applicable · United States · 1 site
Registry update: 29 Dec 2025
NCT07913919
Recruiting
Effect of Anifrolumab on Arterial Inflammation in Systemic Lupus Erythematosus Study
Not applicable · United Kingdom · 1 site
Registry update: 3 Nov 2026
2024-520385-57-01
Recruiting
A study to find how well budoprutug (TNT119) works and how safe it is in participants with Systemic Lupus Erythematosus
Phase 1 · Bulgaria, Spain, Greece, Romania · 8 sites
Registry update: 30 Jun 2026
NCT07403188
Recruiting
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
Phase 2/3 · Germany, United States · 5 sites
Registry update: 11 Feb 2026
NCT07236762
Recruiting
An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 4 Mar 2026
NCT07229742
Recruiting
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
Phase 2 · China · 1 site
Registry update: 1 Dec 2025
NCT07077304
Recruiting
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Not applicable · France · 1 site
Registry update: 5 Jun 2026
NCT07363460
Recruiting
Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN
Phase 2 · China · 1 site
Registry update: 23 Jan 2026

Ordered by registry start date. Freshness and sponsorship never change the order.